Ticker > Company >

Zenotech Laboratorie share price

Zenotech Laboratories Ltd.

BSE: 532039 SECTOR: Pharmaceuticals & Drugs  21k   68   3

76.20
+0.10 (0.13%)
BSE: Today, 04:00 PM

Price Summary

Today's High

₹ 77.9

Today's Low

₹ 74.5

52 Week High

₹ 107.79

52 Week Low

₹ 52.23

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

465.05 Cr.

Enterprise Value

445.37 Cr.

No. of Shares

6.1 Cr.

P/E

69.84

P/B

4.99

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  15.27

CASH

19.69 Cr.

DEBT

0 Cr.

Promoter Holding

68.84 %

EPS (TTM)

₹  1.09

Sales Growth

-3.75%

ROE

9.6 %

ROCE

12.89%

Profit Growth

-28.37 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-3.75%
3 Year22.08%
5 Year25.67%

Profit Growth

1 Year-28.37%
3 Year106.69%
5 Year36.01%

ROE%

1 Year9.6%
3 Year20.67%
5 Year16.78%

ROCE %

1 Year12.89%
3 Year15.52%
5 Year13.07%

Debt/Equity

0

Price to Cash Flow

39.34

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

1.30321004682085

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 68.84 0.00
Jun 2024 68.84 0.00
Mar 2024 68.84 0.00
Dec 2023 68.84 0.00
Sep 2023 68.84 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 106.687585629536% for the Past 3 years.
  • The company has shown a good revenue growth of 22.0755692007782% for the Past 3 years.
  • Company has been maintaining healthy ROE of 20.6708996332301% over the past 3 years.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 40.3331831683494% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 36.8874 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.30321004682085.
  • The company has a high promoter holding of 68.84%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 19.9573041877793.

 Limitations

  • The company is trading at a high PE of 69.84.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 11.53 10.94 9.11 9.91 9.76
Total Expenditure 6.02 5.68 6.33 6.48 7.36
Operating Profit 5.51 5.26 2.78 3.44 2.41
Other Income 0.19 0.28 0.33 0.34 0.34
Interest 0 0 0 0 0
Depreciation 1.81 1.74 1.73 1.73 1.75
Exceptional Items 0 0 0 0 1.35
Profit Before Tax 3.9 3.8 1.37 2.05 2.35
Tax 1.06 0.44 0.71 0.76 1
Profit After Tax 2.83 3.36 0.66 1.29 1.35
Adjusted EPS (Rs) 0.46 0.55 0.11 0.21 0.22

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 26.02 22.45 36.57 42.42 40.83
Total Expenditure 17.04 16.07 19.1 21.72 23.61
Operating Profit 8.98 6.38 17.46 20.7 17.22
Other Income 1.17 0.41 0.63 1.08 1
Interest 0.89 1.55 1.22 0.11 0
Depreciation 4.85 6.46 6.97 7.17 7.09
Exceptional Items 6.37 0 0 0 0
Profit Before Tax 10.78 -1.22 9.9 14.5 11.14
Tax 0 0 -12.27 2.92 2.84
Net Profit 10.78 -1.22 22.18 11.59 8.3
Adjusted EPS (Rs.) 1.77 -0.2 3.63 1.9 1.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 61.03 61.03 61.03 61.03 61.03
Total Reserves -11.4 -12.62 9.61 21.24 29.51
Borrowings 0 20.66 6 0 0
Other N/C liabilities 0.49 1.83 -10.41 -7.36 -4.38
Current liabilities 35.44 14.95 15.58 16.61 13.52
Total Liabilities 85.55 85.84 81.81 91.52 99.68
Assets
Net Block 48.73 74.23 70.91 65.38 65.58
Capital WIP 29.08 2.18 0.28 4.98 1.96
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 1.94 1.98 3.15 4.79 5.75
Other N/C Assets 0.1 0.1 0.1 0.1 0.23
Current Assets 5.71 7.35 7.37 16.26 26.16
Total Assets 85.55 85.84 81.81 91.52 99.68
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 10.78 -1.22 9.9 14.5 11.14
Adjustment -1.68 7.66 8.01 6.86 6.17
Changes in Assets & Liabilities 2.56 -0.59 0.76 0.49 -4.41
Tax Paid -0.28 -0.12 -1 -1.19 -1.07
Operating Cash Flow 11.38 5.74 17.67 20.66 11.82
Investing Cash Flow -20.79 -4.82 -1.84 -5.82 -21.15
Financing Cash Flow -2.7 0.45 -15.87 -6.11 0
Net Cash Flow -12.11 1.38 -0.04 8.73 -9.33

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 68.84 68.84 68.84 68.84 68.84
sun pharmaceutical indust... 68.84 68.84 68.84 68.84 68.84
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 31.16 31.16 31.16 31.16 31.16
dr. jayaram chigurupati 3.59 3.59 3.59 3.59 3.59
minal bharat patel 1.99 1.99 1.99 1.99 1.99
padmasree chigurupati 5.26 5.26 5.26 5.26 5.26
pat financial consultants... 3.98 3.98 3.98 3.98 3.98
zenotech llc 1.14 1.14 1.14 1.14 1.14

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Zenotech Laboratories informs about outcome of board meeting 23 Oct, 4:22 PM Zenotech Laboratorie - Quaterly Results 23 Oct, 3:03 PM Zenotech Laboratorie - Quaterly Results 23 Oct, 3:03 PM Zenotech Laboratorie - Quaterly Results 23 Oct, 3:03 PM Zenotech Laboratories informs about press release 3 Sep, 5:24 PM Zenotech Laboratorie - Quaterly Results 26 Jul, 5:31 PM Zenotech Laboratorie - Quaterly Results 26 Jul, 5:31 PM Zenotech Laboratorie - Quaterly Results 26 Jul, 5:31 PM Zenotech Laboratories informs about newspaper advertisement 3 May, 10:54 AM Zenotech Laboratorie - Quaterly Results 1 May, 8:18 PM Zenotech Laboratorie - Quaterly Results 1 May, 8:18 PM Zenotech Laboratorie - Quaterly Results 29 Jan, 6:39 PM Zenotech Laboratorie - Quaterly Results 29 Jan, 6:39 PM Zenotech Laboratorie - Quaterly Results 29 Jan, 6:39 PM Zenotech Laboratorie - Quaterly Results 30 Oct, 7:00 PM Zenotech Laboratorie - Quaterly Results 30 Oct, 7:00 PM Zenotech Laboratories informs about compliances-certificate 12 Oct, 4:55 PM Zenotech Laboratories informs about press release 6 Sep, 2:05 PM Zenotech Laboratories informs about newspaper publication 2 Sep, 1:01 PM Zenotech Laboratorie - Quaterly Results 1 Aug, 7:48 PM Zenotech Laboratorie - Quaterly Results 1 Aug, 7:48 PM Zenotech Laboratories informs about non-applicability of large corporate entity 3 May, 12:16 PM Zenotech Laboratorie - Quaterly Results 28 Apr, 8:16 PM Zenotech Laboratorie - Quaterly Results 28 Apr, 8:16 PM Zenotech Laboratorie - Quaterly Results 27 Jan, 7:28 PM Zenotech Laboratorie - Quaterly Results 27 Jan, 7:28 PM Zenotech Laboratories informs about compliances-certificate 10 Jan, 5:42 PM Zenotech Laboratorie - Quaterly Results 28 Oct, 7:16 PM Zenotech Laboratorie - Quaterly Results 28 Oct, 7:16 PM Zenotech Laboratories informs about board meeting 20 Oct, 10:19 AM Zenotech Laboratories informs about closure of trading window 26 Sep, 1:01 PM Zenotech Laboratories informs about newspaper advertisements 29 Aug, 12:34 PM Zenotech Laboratories informs about 33rd AGM 27 Aug, 4:35 PM Zenotech Laboratorie - Quaterly Results 22 Jul, 6:50 PM Zenotech Laboratorie - Quaterly Results 22 Jul, 6:50 PM Zenotech Laboratories informs about board meeting 14 Jul, 10:53 AM Zenotech Laboratories informs about certificate 11 Jul, 9:39 AM Zenotech Laboratories informs about closure of trading window 28 Jun, 9:50 AM Zenotech Laboratorie - Quaterly Results 29 Apr, 8:40 PM Zenotech Laboratorie - Quaterly Results 29 Apr, 8:40 PM Zenotech Laboratories informs about disclosure 30 Mar, 12:19 PM Zenotech Laboratories informs about disclosure 30 Mar, 9:54 AM Zenotech Laboratories informs about closure of trading window 24 Mar, 11:34 AM Zenotech Laboratories informs about disclosure 22 Mar, 10:03 AM Zenotech Laboratories informs about trading window closure 28 Dec, 11:01 AM Zenotech Laboratories informs about trading window closure 28 Dec, 10:51 AM Zenotech Laboratorie - Quaterly Results 22 Oct, 6:43 PM Zenotech Laboratories informs about board meeting 14 Oct, 3:42 PM Zenotech Laboratories informs about trading window closure 27 Sep, 10:30 AM Zenotech Laboratories submits annual report 2 Sep, 3:40 PM

Zenotech Laboratorie Stock Price Analysis and Quick Research Report. Is Zenotech Laboratorie an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Zenotech Laboratorie and its performance over the period of time. Zenotech Laboratorie stock price today is Rs 76.2.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Zenotech Laboratorie cash from the operating activity was Rs 11.8226 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Zenotech Laboratorie has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Zenotech Laboratorie , the EPS growth was -28.3675 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Zenotech Laboratorie has OPM of 42.1777920363627 % which is a good sign for profitability.
     
  • ROE: Zenotech Laboratorie have a poor ROE of 9.6043 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Zenotech Laboratorie is Rs 76.2. One can use valuation calculators of ticker to know if Zenotech Laboratorie share price is undervalued or overvalued.
Last Updated on:
Brief about Zenotech Laboratorie
X